TrialInternational journal of clinical oncology2013

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study.

Kimio Ushijima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.